AC Immune News, Reviews & Resources - Labiotech.eu
AC Immune Alzheimer's Drug Reduces Cognitive Decline but Misses Functional Endpoints | BioSpace
AC Immune on Twitter: "Register today to join the live webcast of AC Immune's Key Opinion Leader meeting on treating Alzheimer's in Down syndrome at 8am ET, 11 July 2019. https://t.co/7E06v5ew2s #Downsyndrome #
Genentech, AC Immune reveal more about crenezumab failure
Who is AC Immune? A cutting-edge company with a robust pipeline
ACI-7104 / AC Immune
AC Immune and Roche rocked by Alzheimer's failure
AC Immune's Robust Pipeline focused on neurodegenerative diseases
AC Immune reports positive data from Alzheimer's disease vaccine
AC Immune acquires Parkinson's vaccine candidate
AC Immune: Dementia-Focused Swiss Biotech With A Sad History Of Failures (NASDAQ:ACIU) | Seeking Alpha
AC Immune (@AC_Immune_SA) / Twitter
AC Immune wins $500K to advance ALS diagnostic efforts | ALS News Today
Who is AC Immune? A cutting-edge company with a robust pipeline
AC Immune (@AC_Immune_SA) / Twitter
AC Immune (@AC_Immune_SA) / Twitter
AC Immune's Robust Pipeline focused on neurodegenerative diseases
AC Immune - AnnualReports.com
New Vaccine Formulation Shows Promise for Alzheimer's Target | BioSpace
Morphomer® and SupraAntigen® | AC Immune's Technology Platforms
AC Immune – Swiss Biotech
Treatments & preventive strategies for neurodegenerative diseases
AC Immune Gets €28M from Eli Lilly as Alzheimer's Drug Hits Phase I
Genentech-partnered AC Immune tees up $68M IPO to bankroll Alzheimer's R&D | Fierce Biotech
AC Immune (@AC_Immune_SA) / Twitter
AC Immune show first images from alpha-synuclein PET
